SOURCING
Reference listed drugs
Innovator reference and comparator products from the market of origin your filing requires.
The exact reference your filing names
A bioequivalence study is only as defensible as the reference product it was run against. Obtaining that product — correct strength, correct market of origin, sufficient remaining shelf life, documentation that survives regulatory review — is routinely the slowest step in a generic development programme.
It becomes considerably harder when the reference is discontinued, supply-restricted, sold only through hospital channels, or marketed in a single country where you have no presence. That is the category we work in.
What is included
- FDA and EMA approved reference products
- Sourced from the market of origin your filing requires
- Comparator supply for clinical trial programmes
- Restricted-distribution and limited-supply products
- Batch and expiry confirmed before purchase
- Full purchase documentation and chain of custody
Where this service earns its place
Generic manufacturers
Reference product for bioequivalence, from the market your filing names.
Contract research organisations
Comparator supply matched to the study window.
R&D and formulation teams
Innovator product for development and characterisation work.
Regulatory consultants
Sourcing documentation that survives review.
From first enquiry to delivered goods
Enquiry and quote
Send the product, strength, quantity and destination. We reply with availability, landed pricing and the documents your market needs.
Confirm and document
Specification agreed, registration and export paperwork prepared, supply plan confirmed before anything ships.
Source and verify
Product from licensed sources only, with certificate of analysis, batch records and packaging checked before dispatch.
Ship and hand over
Freight booked, cold chain held, documents travelling with the goods, and the temperature record handed over at delivery.
What buyers ask before they commit
Which market can you source the reference from?
The market of origin your filing requires. Which market that is depends on the authority you are filing with, so we confirm the requirement before sourcing rather than after.
Do you confirm batch and expiry before buying?
Yes. Batch and remaining shelf life are confirmed against your study window before purchase, because a reference product that expires mid-study is of no use to the filing.
Can you source restricted or discontinued products?
That is the category we work in — hospital-only distribution, limited supply, and products marketed in a single country. Feasibility is confirmed honestly before you commit.
What do you need from me?
The product, strength and pack size, the reference market your authority requires, the quantity, and your study window. Registration details and the intended purpose are needed for the purchase documentation.
What documentation comes with the product?
Full purchase documentation and chain of custody, so the sourcing stands up when the dossier is reviewed.
The rest of the chain
Wholesale distribution
Branded and generic medicines, nutraceuticals and surgicals to hospitals, institutions and distributors.
02Contract manufacturing
Production on lines already built, validated and inspected — under your brand, to your specification.
03Named patient supply
Sourcing, permits, cold chain and delivery for a single identified patient, through their physician.
04Exports and international supply
Registration, labelling, permits and shelf-life on arrival resolved before a consignment ships.
05Cold chain and supply chain
Validated packing, data logger monitoring and an excursion protocol agreed in advance.
06Registration assistance
CTD and ACTD dossiers, CPP, free-sale certificates, legalisation and apostille for your authority.
Background reading
How end-to-end pharmaceutical support simplifies healthcare access
Most delays happen in the handoffs between suppliers, not inside them. What end-to-end support actually changes.
Read →Ethical pharmaceutical sourcing: building trust in healthcare supply chains
Falsified medicines enter wherever a legitimate route is slow or expensive. What licensed sourcing requires.
Read →Secure pharmaceutical logistics: protecting medicines from order to delivery
Cold chain failures accumulate in ordinary gaps — collection, storage, transit and handover.
Read →Have a question about reference listed drugs?
Send us the specifics — the product, the destination, the quantity — and you will get a direct answer rather than a brochure.